← Mechanisms of action
SLC6A4
SINGLE PROTEINHomo sapiens
Preferred name: Serotonin transporter ChEMBL ↗
Linked proteins
Drugs acting on this target (43)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| gsk163090 | Antagonist | experimental | Small molecule | SLC6A4 antagonist |
| noribogaine | Antagonist | experimental | Small molecule | SLC6A4 antagonist |
| amitifadine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| amitriptyline (elavil) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| amoxapine (asendin) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| ansofaxine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| bicifadine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| citalopram (celexa) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| clomipramine (anafranil) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| da-8031 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| dapoxetine (priligy) | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| desvenlafaxine (pristiq) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| dosulepin (Prothiaden) | Inhibitor | experimental | Small molecule | Serotonin transporter inhibitor |
| duloxetine (Cymbalta) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| escitalopram (lexapro) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| faxeladol | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| fluoxetine (prozac) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| fluvoxamine (luvox) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| gsk372475 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| ibogaine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| imipramine (tofranil) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| indalpine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| ip2018 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| js1-1-01 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| levomilnacipran (fetzima) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| milnacipran (savella) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| nefazodone (serzone) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| nortriptyline (aventyl) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| paroxetine (paxil) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| protriptyline (vivactil) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| sep-228432 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| sertraline (zoloft) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| snubh-nm-333 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| tedatioxetine | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| trazodone (desyrel) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| uk-390,957 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| venlafaxine (effexor) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| venlaxafine (Effexor) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| vilazodone (viibryd) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| vortioxetine (trintellix) | Inhibitor | approved | Small molecule | SLC6A4 inhibitor |
| xtl-2125 | Inhibitor | experimental | Small molecule | SLC6A4 inhibitor |
| 3,4-Methylenedioxymethamphetamine | Releasing agent | experimental | Small molecule | Sodium-dependent serotonin transporter releasing agent |
| chlorphentermine (pre-sate) | Substrate | approved | Small molecule | SLC6A4 substrate |